•                 New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands planned for later

Ina Verdoold (60) has lived with diabetes for almost her entire life. For years, she used Roche’s Accu-Chek insulin pump. When she was told,

For two years, Jan de Groot (58) from Velserbroek relied on Roche’s Accu‑Chek Insight insulin pump. When Roche announced at the end of 2025

Jannet Storm (61) works three mornings a week as a support assistant in a group of toddlers with physical disabilities. She has had diabetes

We’re excited to share an important update: Kaleido is now immediately available, with no waiting period to get started. Kaleido is the smallest and

Start Today. Ready for What’s Next At ViCentra the company behind Kaleido, we understand that stability and reliability are essential in diabetes management. That’s